Indicator summary: Leaning bullish (3 bullish, 1 bearish, 1 neutral). As of 2026-10-08, the close was $276.44: 2.1% above the 50-day average and 0.7% above the 200-day average, which is rising. RSI (14) is 59, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 59% of the way up its 52-week range of $217.28 to $318.22, on 2.2x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $270.81 | Price 2.1% above |
| 200-day average | $274.65 | Price 0.7% above, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 59 | Neutral range |
| MACD (12, 26, 9) | -0.43 vs -0.94 | Bullish cross in the last 10 days |
| 52-week range | $217.28 to $318.22 | 59% of the way up the range |
| Volume vs 20-day average | 2.2x | Heavy |
Base rates use CME's own daily history since 2002; they describe the past, not a forecast.
As of 2026-10-08, CME's 14-day RSI is 59, which is in the neutral range between 30 and 70.
Yes. CME closed at $276.44 on 2026-10-08, 0.7% above its 200-day average of $274.65, which is rising. When it closed above its 200-day average (4,366 days), it was higher 63 trading days later 67% of the time, median +4.7%.
Yes. CME closed at $276.44 on 2026-10-08, 2.1% above its 50-day average of $270.81. When it closed above its 50-day average (3,652 days), it was higher 63 trading days later 66% of the time, median +4.8%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-08 the MACD line is -0.43 against a signal line of -0.94, so MACD is bullish.
No. At $276.44 it sits 59% of the way up its 52-week range of $217.28 to $318.22, 13.1% below the high.
Leaning bullish: 3 of 5 indicators are bullish and 1 bearish as of 2026-10-08 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
CME analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.